The effect of topical 0.05% cyclosporine on recurrence following pterygium surgery

Ece Turan-Vural¹, Banu Torun-Acar¹, S Argun Kivanc², Suphi Acar¹¹Haydarpaşa Numune Education and Research Hospital, Ophthalmology Clinic, Istanbul, Turkey; ²Umranıye Education and Research Hospital, Ophthalmology Clinic, I...

Full description

Bibliographic Details
Main Authors: Turan-Vural E, Torun-Acar BT, Kivanc SA, Acar S
Format: Article
Language:English
Published: Dove Medical Press 2011-06-01
Series:Clinical Ophthalmology
Online Access:http://www.dovepress.com/the-effect-of-topical-005-cyclosporine-on-recurrence-following-pterygi-a7756
id doaj-ec46a63564cd478c863f6f4736f5b407
record_format Article
spelling doaj-ec46a63564cd478c863f6f4736f5b4072020-11-24T21:42:08ZengDove Medical PressClinical Ophthalmology1177-54671177-54832011-06-012011default881885The effect of topical 0.05% cyclosporine on recurrence following pterygium surgeryTuran-Vural ETorun-Acar BTKivanc SAAcar SEce Turan-Vural¹, Banu Torun-Acar¹, S Argun Kivanc², Suphi Acar¹¹Haydarpaşa Numune Education and Research Hospital, Ophthalmology Clinic, Istanbul, Turkey; ²Umranıye Education and Research Hospital, Ophthalmology Clinic, Istanbul, TurkeyPurpose: To investigate the role of postoperative topical 0.05% cyclosporine A (CsA) eye drops (Restasis®, Allergan Pharmaceutical) in the prevention of recurrence among patients with primary pterygium treated with bare-sclera technique.Methods: In this prospective randomized controlled study, 36 eyes (34 patients) with primary pterygium were randomized into two groups: Group I comprised 18 eyes (18 patients), and Group II comprised 18 eyes (16 patients). Bare sclera technique was performed in both groups. In Group I, 0.05% CsA was administered postoperatively at 6-hour intervals for 6 months, and Group II did not receive any cyclosporine treatment. The patients were assessed for recurrence, side effects, and complications at postoperative 1 and 7 days as well as each month during the following year. Conjunctival advances which showed a limbus higher than 1 mm were recognized as recurrence.Results: Recurrence occurred in four patients (22.2%) in Group I and in eight (44.4%) patients in Group II.Conclusion: Postoperative application of low-dose CsA can be effective for preventing recurrences after primary pterygium surgery.Keywords: primary pterygium, cyclosporine A, bare sclerahttp://www.dovepress.com/the-effect-of-topical-005-cyclosporine-on-recurrence-following-pterygi-a7756
collection DOAJ
language English
format Article
sources DOAJ
author Turan-Vural E
Torun-Acar BT
Kivanc SA
Acar S
spellingShingle Turan-Vural E
Torun-Acar BT
Kivanc SA
Acar S
The effect of topical 0.05% cyclosporine on recurrence following pterygium surgery
Clinical Ophthalmology
author_facet Turan-Vural E
Torun-Acar BT
Kivanc SA
Acar S
author_sort Turan-Vural E
title The effect of topical 0.05% cyclosporine on recurrence following pterygium surgery
title_short The effect of topical 0.05% cyclosporine on recurrence following pterygium surgery
title_full The effect of topical 0.05% cyclosporine on recurrence following pterygium surgery
title_fullStr The effect of topical 0.05% cyclosporine on recurrence following pterygium surgery
title_full_unstemmed The effect of topical 0.05% cyclosporine on recurrence following pterygium surgery
title_sort effect of topical 0.05% cyclosporine on recurrence following pterygium surgery
publisher Dove Medical Press
series Clinical Ophthalmology
issn 1177-5467
1177-5483
publishDate 2011-06-01
description Ece Turan-Vural¹, Banu Torun-Acar¹, S Argun Kivanc², Suphi Acar¹¹Haydarpaşa Numune Education and Research Hospital, Ophthalmology Clinic, Istanbul, Turkey; ²Umranıye Education and Research Hospital, Ophthalmology Clinic, Istanbul, TurkeyPurpose: To investigate the role of postoperative topical 0.05% cyclosporine A (CsA) eye drops (Restasis®, Allergan Pharmaceutical) in the prevention of recurrence among patients with primary pterygium treated with bare-sclera technique.Methods: In this prospective randomized controlled study, 36 eyes (34 patients) with primary pterygium were randomized into two groups: Group I comprised 18 eyes (18 patients), and Group II comprised 18 eyes (16 patients). Bare sclera technique was performed in both groups. In Group I, 0.05% CsA was administered postoperatively at 6-hour intervals for 6 months, and Group II did not receive any cyclosporine treatment. The patients were assessed for recurrence, side effects, and complications at postoperative 1 and 7 days as well as each month during the following year. Conjunctival advances which showed a limbus higher than 1 mm were recognized as recurrence.Results: Recurrence occurred in four patients (22.2%) in Group I and in eight (44.4%) patients in Group II.Conclusion: Postoperative application of low-dose CsA can be effective for preventing recurrences after primary pterygium surgery.Keywords: primary pterygium, cyclosporine A, bare sclera
url http://www.dovepress.com/the-effect-of-topical-005-cyclosporine-on-recurrence-following-pterygi-a7756
work_keys_str_mv AT turanvurale theeffectoftopical005cyclosporineonrecurrencefollowingpterygiumsurgery
AT torunacarbt theeffectoftopical005cyclosporineonrecurrencefollowingpterygiumsurgery
AT kivancsa theeffectoftopical005cyclosporineonrecurrencefollowingpterygiumsurgery
AT acars theeffectoftopical005cyclosporineonrecurrencefollowingpterygiumsurgery
AT turanvurale effectoftopical005cyclosporineonrecurrencefollowingpterygiumsurgery
AT torunacarbt effectoftopical005cyclosporineonrecurrencefollowingpterygiumsurgery
AT kivancsa effectoftopical005cyclosporineonrecurrencefollowingpterygiumsurgery
AT acars effectoftopical005cyclosporineonrecurrencefollowingpterygiumsurgery
_version_ 1716664173649199104